Ovarian Cancer: Hope's Patient Story
This ovarian cancer diagnosis at a glance
- Sex
- female
- Treatment
- surgery and chemotherapy
- Outcome
- Living With Cancer
Treatment course, step by step
- Underwent debulking surgery with a total abdominal hysterectomy.
- Completed about 5 months of intraperitoneal chemotherapy.
- During a later ovarian-cancer recurrence in the COVID-19 pandemic, received additional chemotherapy.
What happened, in summary
Hope Aguilar’s ovarian-cancer journey began with a late diagnosis in December 2011. Her cancer was identified as high-grade serous ovarian cancer. She underwent debulking surgery with a total abdominal hysterectomy, followed by about 5 months of intraperitoneal chemotherapy. She described those early months as physically difficult, while family, friends, faith, and her military background helped her keep moving forward.
After treatment, Hope began sharing her experience publicly and wrote a book about her journey in 2014. Years later, during the COVID-19 pandemic, the ovarian cancer recurred and she went through chemotherapy again. Practical support became especially important during that period, including meal assistance when daily tasks were difficult.
More than 14 years after her December 2011 diagnosis, Hope is described as a survivor and advocate. She created the Teal Time with Hope podcast and continues using her experience to support other people affected by ovarian cancer. Her story centers on long-term survivorship, recurrence, community support, and finding purpose through advocacy.
Where this story comes from
This is a lay summary of an account first published by National Ovarian Cancer Coalition. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Chemotherapy for Ovarian Cancer 126 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer